Neumora Therapeutics, Inc. (NMRA)
(Delayed Data from NSDQ)
$15.60 USD
+0.09 (0.58%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $15.60 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.38 | 12.58% |
Earnings Summary
For their last quarter, Neumora Therapeutics, Inc. (NMRA) reported earnings of -$0.37 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for NMRA's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year increase of 66.67%.
Earnings History
Price & Consensus
Zacks News for NMRA
Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
NMRA: What are Zacks experts saying now?
Zacks Private Portfolio Services